1.10
0.45%
-0.005
Handel nachbörslich:
1.10
Finanzdaten der Rapt Therapeutics Inc-Aktie (RAPT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
2.10%
32.52
|
33.22 | 33.92 | 28.36 | 31.56 |
Depreciation and Amortization |
2.79%
0.314
|
0.323 | 0.30 | 0.30 | 0.299 |
Operating Income/Loss |
2.10%
-32.52
|
-33.22 | -33.92 | -28.36 | -31.56 |
Nonoperating Income/Loss |
14.69%
1.997
|
2.341 | 2.548 | 3.084 | 2.291 |
Income/Loss From Continuing Operations Before Tax |
1.15%
-30.52
|
-30.88 | -31.37 | -25.28 | -29.27 |
Income/Loss From Continuing Operations After Tax |
1.15%
-30.52
|
-30.88 | -31.37 | -25.28 | -29.27 |
Net Income/Loss
|
1.15%
-30.52
|
-30.88 | -31.37 | -25.28 | -29.27 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
250.91K%
38.63
|
0.0154 | 38.36 | 38.33 | 38.28 |
Diluted Average Shares |
250.91K%
38.63
|
0.0154 | 38.36 | 38.33 | 38.28 |
Basic Earnings Per Share |
2.47%
-0.79
|
-0.81 | -0.82 | -0.66 | -0.76 |
Diluted Earnings Per Share |
2.47%
-0.79
|
-0.81 | -0.82 | -0.66 | -0.76 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):